SK Capital Partners have made an investment in VanDeMark Chemical in partnership with Comvest Partners, which has been a co-owner since 2019. The amount involved was not disclosed but VanDeMark said that this would “serve as a catalyst for a new strategic direction as the company seeks to deepen and expand its presence in fine chemistries for the global life science market”.
As had been widely anticipated, SK Capital Partners operation Archroma has entered into a definitive agreement to acquire the Singapore-based Textile Effects business of Huntsman. Closing is expected to take place in 1H 2023, subject to customary conditions and regulatory approval. Textile Effects had sales of $772 million and adjusted EBITDA of $94 million in the last financial year.
SK Capital Partners has made two further acquisitions in May, buying SK Capital Partners from Miami-based investment firm HIG Capital in a deal that is expected to close in Q3 subject to customary closing conditions, and Florachem from an affiliate of Carmelina Capital. Terms were not disclosed in either deal.
Valtris, which is headquartered in Independence, Ohio, has nine manufacturing facilities worldwide. It makes speciality additives and chemicals that impart including flexibility, stability, processability and flame retardance to plastics and other materials.
Miami-based HIG Capital alternative investment firm HIG Capital has agreed to sell Valtris Specialty Chemicals to an affiliate of funds managed by SK Capital Partners. The transaction is expected to close in Q3, subject to customary closing conditions. Terms were not disclosed.
Valtris is located in Independence, Ohio, and operates nine manufacturing facilities worldwide. It makes speciality polymer additives to impart flexibility, stability processability and flame retardance, plus speciality chemicals for a wide range of end markets.
Clariant has completed the previously announced sale of most of its Pigments business to Heubach Group and SK Capital Partners, completing its transformation into a speciality chemicals firm. The business has about 3,000 employees and revenues of €1 billion/year.
The deal gives Pigments a base enterprise value of CHF 805 million, subject to closing accounts adjustments and before a potential earn-out payment of CHF 50 million depending on its financial performance in 2021. Clariant has retained a 20% stake in the new holding company. in order to profit from its future growth
CDMO Seqens has confirmed that its planned change of ownership has been completed, with SK Capital, a private investment firm focused on the specialty materials, chemicals and pharmaceuticals sectors, becoming the majority shareholder.
SK Capital Partners has announced that it, Eurazeo and other shareholders in Seqens have entered a formal agreement for it to acquire Seqens. This follows a period of exclusive negotiations and the agreement of the employee representative body. This remains subject to regulatory approval. S